Ex-Salix CFO Pays $1M To End Claims He Misled Investors
The U.S. Securities and Exchange Commission on Friday charged Salix Pharmaceuticals Ltd. and its former chief financial officer with repeatedly misleading investors about the amount of Salix drugs that wholesale customers...To view the full article, register now.
Already a subscriber? Click here to view full article